Patient Flow on Total Therapy
| Started Treatment . | Off-Study Reasons . | |||||
|---|---|---|---|---|---|---|
| Phase of Therapy . | N . | % . | Toxicity (deaths) . | Platelets <50,000/μL . | Progression . | Declined . |
| Induction | 231 | 100 | 16 (8) | 0 | 6 | 7/73-150 |
| Tx-1 | 195 | 84 | 11 (2) | 0 | 9 | 10 |
| Tx-2 | 165 | 71 | 12 (6) | 10 | 2 | 13 |
| IFN | 128 | 56 | 34 (0) | 0 | 25 | 16 |
| Started Treatment . | Off-Study Reasons . | |||||
|---|---|---|---|---|---|---|
| Phase of Therapy . | N . | % . | Toxicity (deaths) . | Platelets <50,000/μL . | Progression . | Declined . |
| Induction | 231 | 100 | 16 (8) | 0 | 6 | 7/73-150 |
| Tx-1 | 195 | 84 | 11 (2) | 0 | 9 | 10 |
| Tx-2 | 165 | 71 | 12 (6) | 10 | 2 | 13 |
| IFN | 128 | 56 | 34 (0) | 0 | 25 | 16 |
Seven patients without insurance coverage proceeded to nontransplant arm of study (see text).